Court of Appeal to reconsider £69m fines over ‘excessive’ pricing of epilepsy drug

Previously, the Competition and Markets Authority found that drug companies Pfizer and Flynn Pharma used their dominant market positions to hike the prices of phenytoin sodium capsules by 2,300–2,600% between 2012 and 2016.…